Discoveries and Breakthroughs in Science

Who's documenting the latest breakthroughs in nutrition and lifestyle medicine? The scientific professionals at Metagenics! Our renowned scientists and clinicians are actively published in recognized journals. To date, over 200 articles from our expert group have been published in peer-reviewed journals. Look at the many examples below to see how we take leading positions on the important role of nutrition and lifestyle medicine in improving health and reversing chronic illness.

Veera R. Konda, Anuradha Desai, Gary Darland, Jeffrey S. Bland, Matthew L. Tripp. Rho iso-alpha acids from hops inhibit the GSK-3/NF-κB pathway and reduce inflammatory markers associated with bone and cartilage degradation. J Inflamm. 2009 Aug 27;6:26.PMID: 19712471.

RIAA selectively inhibited the NF-κB pathway while having no effect on ERK1/2, p38 and JNK phosphorylation in LPS-stimulated RAW 264.7 cells. RIAA also inhibited GSK-3α/β kinase activity and GSK-3β dependent phosphorylation of β-catenin in RAW 264.7 cells. In addition, RIAA inhibited NF-κB-mediated inflammatory markers in various cell models, including nitric oxide in LPS-stimulated RAW 264.7 cells, RANKL-mediated TRAP activity in transformed osteoclasts, and TNF-α/IL-1β-mediated MMP-13 expression in SW1353 human chondrosarcoma cells. Finally, in a mouse model of collagen-induced arthritis, RIAA ameliorated joint damage as evidenced by significant reduction of the arthritis index and histology score. RIAA may have potential as an anti-inflammatory therapeutic.